SBIR/STTR Research Award
IGF OT IGF NASCARE A MOBILE TOOL FOR DIAGNOSIS AND TREATMENT OF NEONATAL ABSTINENCE SYNDROME SEPTEMBER MARCH N DA
Award amount
$147,354Program and phase
SBIR · Phase IAward year
2016Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- DIMAGI, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- FY2NCML2TTW7
- Solicitation number
- Not reported
- Topic code
- NIDA
Research abstract
SBIR Topic addresses the demand to promote awareness and knowledge of the best practice in management of Neonatal Abstinence Syndrome NAS The need is caused by clinical rigor and raised concerns among neonatal and pediatric practitioners regarding a constellation of various withdrawal symptoms and treatment approaches The ultimate goal of this contract is to develop a skill building Primer and Reference Tool to assist clinicians in identifying interpretation scoring and responding to NAS symptoms toward improving neonatal outcomes
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- A novel digital platform for measurement-based peer supervision of non-specialist providers conducting brief psychological interventions
- A Digital Serious Illness Conversation Coach
- A conversational agent to support remote care for individuals with substance use disorder
- A novel digital platform for measurement-based peer supervision of non-specialist providers conducting brief psychological interventions
- SurvivorCare: A digital health solution to support long-term cancer survivorship using patient navigation
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
- Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder
- A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
- Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.
- Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)
Research funding history
24 SBIR/STTR records share this UEI (2006–2024). Reported award amounts total $15,464,962. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services